BDBM50099757 4-(Carboxymethyl-carbamoyl)-4-{[1-(2-{2-[(9,10-dioxo-9,10-dihydro-phenanthrene-2-carbonyl)-amino]-5-guanidino-pentanoylamino}-5-guanidino-pentanoyl)-pyrrolidine-2-carbonyl]-amino}-butyric acid::CHEMBL298387
SMILES NC(=N)NCCCC(NC(=O)c1ccc2-c3ccccc3C(=O)C(=O)c2c1)C(=O)NC(CCCNC(N)=N)C(=O)N1CCCC1C(=O)NC(CCC(O)=O)C(=O)NCC(O)=O
InChI Key InChIKey=BSFCDFVPTVKXDM-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50099757
TargetReceptor-type tyrosine-protein phosphatase C(Human)
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair
